Results 301 to 310 of about 1,103,793 (328)
Some of the next articles are maybe not open access.
Drug intelligence & clinical pharmacy, 1985
Numerous beta-lactamase inhibitors have been developed to overcome the problems of bacterial resistance to beta-lactam antibiotics. One such agent, clavulanic acid, has been combined with amoxicillin, and the combination is effective against many amoxicillin-resistant organisms. Clinical studies have demonstrated the efficacy of amoxicillin/clavulanate
openaire +1 more source
Numerous beta-lactamase inhibitors have been developed to overcome the problems of bacterial resistance to beta-lactam antibiotics. One such agent, clavulanic acid, has been combined with amoxicillin, and the combination is effective against many amoxicillin-resistant organisms. Clinical studies have demonstrated the efficacy of amoxicillin/clavulanate
openaire +1 more source
Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria
Expert Opinion on Pharmacotherapy, 2016Ryan G. D’Angelo +3 more
semanticscholar +1 more source
Beta-lactamases from Yersinia enterocolitica.
Journal of general microbiology, 1975Two beta-lactamases, A and B, have been shown to be present in a strain of Yersinia enterocolitica (w222). Beta-Lactamase A hydrolyses a variety of penicillins and cephalosporins. This enzyme is sensitive to thiol reagents, is only partially inhibited by 0-1 mM-cloxacillin and has a molecular weight of approximatley 20,000.beta-Lactamase B shows strong
Cornelis, G., Abraham, E. P.
openaire +2 more sources
Clinical microbiology reviews, 2009
AmpC beta-lactamases are clinically important cephalosporinases encoded on the chromosomes of many of the Enterobacteriaceae and a few other organisms, where they mediate resistance to cephalothin, cefazolin, cefoxitin, most penicillins, and beta-lactamase inhibitor-beta-lactam combinations.
openaire +1 more source
AmpC beta-lactamases are clinically important cephalosporinases encoded on the chromosomes of many of the Enterobacteriaceae and a few other organisms, where they mediate resistance to cephalothin, cefazolin, cefoxitin, most penicillins, and beta-lactamase inhibitor-beta-lactam combinations.
openaire +1 more source
International journal of clinical practice, 2012
L. Briongos-Figuero +8 more
semanticscholar +1 more source
L. Briongos-Figuero +8 more
semanticscholar +1 more source